You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hemoglobinuria

Showing 26 - 50 of 316
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Paroxysmal Nocturnal Hemoglobinuria in ESUS & ETUS

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • +3 more
    • London, Ontario, Canada
      London Health Sciences Centre
    May 10, 2022

    Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Hemoglobinuria Trial in Worldwide (Pegcetacoplan)

    Recruiting
    • Paroxysmal Nocturnal Hemoglobinuria (PNH)
    • Paroxysmal Hemoglobinuria
    • Atlanta, Georgia
    • +9 more
    Jul 18, 2022

    Paroxysmal Nocturnal Hemoglobinuria Trial in Changsha (MY008211A tablets, MY008211A tablets matched )

    Active, not recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • MY008211A tablets
    • MY008211A tablets matched placebo
    • Changsha, Hunan, China
      The Third Hospital of Changsha
    Apr 13, 2023

    Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (Danicopan)

    Completed
    Has Results
    • Paroxysmal Nocturnal Hemoglobinuria (PNH)
    • Florence, Italy
    • +4 more
    May 31, 2022

    Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial run

    Recruiting
    • Severe Aplastic Anemia (SAA)
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 28, 2023

    Paroxysmal Nocturnal Hemoglobinuria, PNH Trial in Worldwide (Ravulizumab)

    Completed
    Has Results
    • Paroxysmal Nocturnal Hemoglobinuria
    • PNH
    • Ravulizumab
    • Toronto, Ontario, Canada
    • +15 more
    Dec 7, 2022

    Paroxysmal Nocturnal Hemoglobinuria Trial in Whittier (Ravulizumab, Pozelimab, Cemdisiran)

    Recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • Whittier, California
    • +8 more
    Nov 29, 2022

    Paroxysmal Nocturnal Hemoglobinuria Trial in Changsha (MY008211A tablets, Placebo)

    Active, not recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • MY008211A tablets
    • Placebo
    • Changsha, Hunan, China
      The Third Hospital of Changsha
    Nov 30, 2022

    Paroxysmal Nocturnal Hemoglobinuria Trial in Leeds (Pozelimab, Cemdisiran)

    Recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • Leeds, United Kingdom
      Regeneron Study Site
    Apr 13, 2022

    Paroxysmal Nocturnal Hemoglobinuria Trial in China (Crovalimab)

    Active, not recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • Changchun City, China
    • +5 more
    Jul 11, 2022

    Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (BCX9930 monotherapy, Placebo)

    Active, not recruiting
    • Paroxysmal Nocturnal Hemoglobinuria (PNH)
    • BCX9930 monotherapy
    • Placebo
    • Ampang, Malaysia
    • +3 more
    Dec 15, 2022

    Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry

    Recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
      • Boston, Massachusetts
        Contact the PNH Registry at Alexion Pharmaceuticals, Inc. for wo
      Dec 7, 2021

      Paroxysmal Nocturnal Hemoglobinuria Trial (Danicopan)

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • Baltimore, Maryland
      • +4 more
      Feb 1, 2023

      Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (LNP023)

      Completed
      • Paroxysmal Nocturnal Hemoglobinuria
      • Seoul, Korea, Republic of
      • +4 more
      Apr 5, 2022

      Paroxysmal Nocturnal Hemoglobinuria, PNH Trial in Austria, South Africa, United Kingdom (BCX9930)

      Active, not recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • PNH
      • Vienna, Austria
      • +3 more
      Feb 15, 2022

      Paroxysmal Hemoglobinuria, Nocturnal Trial in Worldwide (Crovalimab, Placebo)

      Active, not recruiting
      • Paroxysmal Hemoglobinuria, Nocturnal
      • Paris, France
      • +18 more
      Dec 5, 2022

      Paroxysmal Nocturnal Hemoglobinuria Trial in China (KP104)

      Not yet recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • Beijing, China
      • +3 more
      Jul 25, 2022

      Paroxysmal Nocturnal Hemoglobinuria Trial in Adelaide (KP104, Placebo)

      Active, not recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • Adelaide, Australia
        CMAX Clinical Research
      Aug 4, 2022

      Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (BCX9930, Eculizumab, Ravulizumab)

      Active, not recruiting
      • Paroxysmal Nocturnal Hemoglobinuria (PNH)
      • Paris, France
      • +6 more
      Dec 15, 2022

      Paroxysmal Nocturnal Hemoglobinuria Trial in Austria, South Africa, United Kingdom (BCX9930, Placebo)

      Completed
      • Paroxysmal Nocturnal Hemoglobinuria
      • Vienna, Austria
      • +3 more
      Feb 15, 2022

      Paroxysmal Nocturnal Hemoglobinuria, C3 Glomerulopathy, IgA Nephropathy Trial in Korea, Republic of, New Zealand, Thailand

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • +2 more
      • Camperdown, New South Wales, Australia
      • +19 more
      Sep 13, 2022

      Paroxysmal Nocturnal Hemoglobinuria Trial in Whittier (Cemdisiran, Eculizumab, Pozelimab)

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • Whittier, California
        Regeneron Research Facility
      Jan 28, 2022

      Paroxysmal Nocturnal Hemoglobinuria Trial in China

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
        • Hefei, Anhui, China
        • +23 more
        Nov 23, 2023

        Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (APL-2)

        Completed
        Has Results
        • Paroxysmal Nocturnal Hemoglobinuria
        • Cali, Colombia
        • +29 more
        Oct 14, 2022

        Paroxysmal Nocturnal Hemoglobinuria (PNH), CD55-deficient Protein-losing Enteropathy (PLE), CD59 Deficiency Trial (Pozelimab)

        Available
        • Paroxysmal Nocturnal Hemoglobinuria (PNH)
        • +2 more
        • (no location specified)
        Jan 28, 2022